Medicines, Ethics and Practice (MEP)

Your go-to guide for good practice

No long lists of statutory obligations here – just everyday, practical tools and guidance to help you make the right decisions.

When to dispense medicines. When not to. When to raise an alarm.

With the MEP by your side, you’ll feel confident you’re making the right decisions.

Download your MEP here


Non-members can purchase a copy of the MEP from the Pharmaceutical Press.

NOTE: The publication of MEP 44 has been postponed until July 2021 as a result of the coronavirus pandemic.

Details of significant changes/additions will be posted below.  If you have any queries please contact RPS Support: [email protected]

If you would like to contribute to improving future issues of MEP email us to see about joining the advisory panel: [email protected]

RPS members get free 24/7 e-Library access


If you were an RPS member, you’d get 24/7 access to essential pharmacy texts whenever and wherever you wanted.

You could also check thousands of journal abstracts and full-text articles from Medline Complete and the Biomedical Reference Collection.

And if you were an RPS member, e-Library access would come free with your membership.

The RPS is here to support our members facing the challenges of COVID-19.

Visit our e-Library today

MEP 43 corrections

Amendments in italics, additions and new information

Page Content Changes
56 Patient Group Directions (PGDs) Guidance for provisionally registered pharmacists on operating under PGDs is available from Specialist Pharmacy Service.

Pandemic exemptions

See RPS COVID-19 pages for the latest information. Includes guidance on ‘Ethical, professional decision-making in the COVID-19 pandemic’, and guidance on controlled drugs contingency legislation for: ‘Emergency supply of controlled drugs’, ‘Supply of controlled drugs under a Serious Shortage Protocol’, and ‘Changing the intervals of instalments during a pandemic’.


Dispensing sodium valproate for girls and women

When supplying valproate, pharmacists should also:

* Provide a patient card every time valproate is dispensed

* Dispense valproate preparations in original packs whenever possible.  If dispensing in 'white boxes' ensure a patient information leaflet is provided and a valproate warning label/sticker added to the box


Optometrist independent prescriber - other applicable considerations

Optometrist independent prescriber - other applicable considerations

Amend to read: For ocular conditions affecting the eye and surrounding tissue only (but not parenteral preparations)


Supplementary prescriber

Paramedics should be added to the list of Supplementary Prescribers


109 - 110 Cannabidiol products A licensed cannabidiol preparation is now available. Epidyolex - a schedule 5 controlled drug, is licensed for use as an adjunct therapy of seizures associated with Lennon-Gastaut syndrome or Dravet syndrome in conjunction with clobazam, for patients 2 years of age and older.  Further information on the use of Epidyolex can be found in the Summary of Product Characteristics.

Have you visited our e-Library?


The MEP is just one of the essential texts we offer.

Our e-Library, which is free to use for all members, offers many other essential texts, such as Dale and Appelbe's Pharmacy and Medicines Law.

Browse the RPS e-Library